Abstract:
Transgenic microbial strains are provided which contain the genes required for PHA formation integrated on the chromosome. The strains are advantageous in PHA production processes, because (1) no plasmids need to be maintained, generally obviating the required use of antibiotics or other stabilizing pressures, and (2) no plasmid loss occurs, thereby stabilizing the number of gene copies per cell throughout the fermentation process, resulting in homogeneous PHA product formation throughout the production process. Genes are integrated using standard techniques, preferably transposon mutagenesis. In a preferred embodiment wherein mutiple genes are incorporated, these are incorporated as an operon. Sequences are used to stabilize mRNA, to induce expression as a function of culture conditions (such as phosphate concentration), temperature, and stress, and to aid in selection, through the incorporation of selection markers such as markers conferring antibiotic resistance.

Description:
CROSS-REFERENCE TO RELATED APPLICATIONS  
       [0001]    Priority is claimed to U.S. provisional application Serial No. 60/096,852, filed Aug. 18, 1998, the teachings of which are incorporated herein. 
     
    
     
       BACKGROUND OF THE INVENTION  
         [0002]    The present invention is generally in the field of biosynthesis of poly(3-hydroxyalkanoates), and more particularly to improved microbial strains useful in commercial production of polyhydroxyalkanoates.  
           [0003]    Poly(3-hydroxyalkanoates) (PHAs) are biological polyesters synthesized by a broad range of bacteria. These polymers are biodegradable and biocompatible thermoplastic materials, produced from renewable resources, with a broad range of industrial and biomedical applications (Williams &amp; Peoples,  CHEMTECH  26:38-44 (1996)). PHA biopolymers have emerged from what was originally considered to be a single homopolymer, poly-3-hydroxybutyrate (PHB) into a broad class of polyesters with different monomer compositions and a wide range of physical properties. About 100 different monomers have been incorporated into the PHA polymers (Steinbuchel &amp; Valentin,  FEMS Microbiol. Lett.  128:219-28 (1995)).  
           [0004]    It has been useful to divide the PHAs into two groups according to the length of their side chains and their biosynthetic pathways. Those with short side chains, such as PHB, a homopolymer of R-3-hydroxybutyric acid units, are crystalline thermoplastics, whereas PHAs with long side chains are more elastomeric. The former have been known for about seventy years (Lemoigne &amp; Roukhelman, 1925), whereas the latter materials were discovered relatively recently (deSmet et al.,  J. Bacteriol.  154:870-78 (1983)). Before this designation, however, PHAs of microbial origin containing both (R)-3-hydroxybutyric acid units and longer side chain (R)-3-hydroxyacid units from C 5  to C 16  had been identified (Wallen &amp; Rohweder,  Environ. Sci. Technol.  8:576-79 (1974)). A number of bacteria which produce copolymers of (R)-3-hydroxybutyric acid and one or more long side chain hydroxyacid units containing from five to sixteen carbon atoms have been identified (Steinbuchel &amp; Wiese,  Appl. Microbiol. Biotechnol.  37:691-97 (1992); Valentin et al.,  Appl. Microbiol. Biotechnol.  36:507-14 (1992); Valentin et al.,  Appl. Microbiol. Biotechnol.  40:710-16 (1994); Abe et al.,  Int. J. Biol. Macromol.  16:115-19 (1994); Lee et al.,  Appl. Microbiol. Biotechnol.  42:901-09 (1995); Kato et al.,  Appl. Microbiol. Biotechnol.  45:363-70 (1996); Valentin et al.,  Appl. Microbiol. Biotechnol.  46:261-67 (1996); U.S. Pat. No. 4,876,331 to Doi). A combination of the two biosynthetic pathways outlined described above provide the hydroxyacid monomers. These copolymers can be referred to as PHB-co-HX (where X is a 3-hydroxyalkanoate or alkanoate or alkenoate of 6 or more carbons). A useful example of specific two-component copolymers is PHB-co-3-hydroxyhexanoate (PHB-co-3HH) (Brandl et al.,  Int. J. Biol. Macromol.  11:49-55 (1989); Amos &amp; Mclnerey,  Arch. Microbiol.  155:103-06 (1991); U.S. Pat. No. 5,292,860 to Shiotani et al.).  
           [0005]    PHA production by many of the microorganisms in these references is not commercially useful because of the complexity of the growth medium, the lengthy fermentation processes, or the difficulty of down-stream processing of the particular bacterial strain. Genetically engineered PHA production systems with fast growing organisms such as  Escherichia coli  have been developed. Genetic engineering also allows for the improvement of wild type PHA production microbes to improve the production of specific copolymers or to introduce the capability to produce different PHA polymers by adding PHA biosynthetic enzymes having different substrate-specificity or even kinetic properties to the natural system. Examples of these types of systems are described in Steinbuchel &amp; Valentin,  FEMS Microbiol. Lett.  128:219-28 (1995). PCT WO 98/04713 describes methods for controlling the molecular weight using genetic engineering to control the level of the PHA synthase enzyme. Commercially useful strains, including  Alcaligenes eutrophus  (renamed as  Ralstonia eutropha ),  Alcaligenes latus, Azotobacter vinlandii , and Pseudomonads, for producing PHAs are disclosed in Lee,  Biotechnology  &amp;  Bioengineering  49:1-14 (1996) and Braunegg et al., (1998), J. Biotechnology 65: 127-161.  
           [0006]    The development of recombinant PHA production strains has followed two parallel paths. In one case, the strains have been developed to produce copolymers, a number of which have been produced in recombinant  E. coli . These copolymers include poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV), poly(3-hydroxybutyrate-co-4-hydroxybutyrate) (P3HB-co-4HB), poly(4-hydroxybutyrate) (P4HB) and long side chain PHAs comprising 3-hydroxyoctanoate units (Madison and Huisman, 1999. Strains of  E. coli  containing the phb genes on a plasmid have been developed to produce P(3HB-3HV) (Slater, et al.,  Appl. Environ. Microbiol.  58:1089-94 (1992); Fidler &amp; Dennis,  FEMS Microbiol. Rev.  103:231-36 (1992); Rhie &amp; Dennis,  Appl. Environ. Micobiol.  61:2487-92 (1995); Zhang, H. et al.,  Appl. Environ. Microbiol.  60:1198-205 (1994)). The production of P(4HB) and P(3HB-4HB) in  E. coli  is achieved by introducing genes from a metabolically unrelated pathway into a P(3HB) producer (Hein, et al.,  FEMS Microbiol. Lett.  153:411-18 (1997); Valentin &amp; Dennis,  J. Biotechnol.  58:33-38 (1997)).  E. coli  also has been engineered to produce medium short chain polyhydroxyalkanoates (msc-PHAs) by introducing the phaC1 and phaC2 gene of  P. aeruginosa  in a fadB::kan mutant (Langenbach, et al.,  FEMS Microbiol. Lett.  150:303-09 (1997); Qi, et al.,  FEMS Microbiol. Lett.  157:155-62 (1997)).  
           [0007]    Although studies demonstrated that expression of the  A. eutrophus  PHB biosynthetic genes encoding PHB polymerase, -ketothiolase, and acetoacetyl-CoA reductase in  E. coli  resulted in the production of PHB (Slater, et al.,  J. Bacteriol.  170:4431-36 (1988); Peoples &amp; Sinskey,  J. Biol. Chem.  264:15298-303 (1989); Schubert, et al.,  J. Bacteriol.  170:5837-47 (1988)), these results were obtained using basic cloning plasmid vectors and the systems are unsuitable for commercial production since these strains lacked the ability to accumulate levels equivalent to the natural producers in industrial media.  
           [0008]    For commercial production, these strains have to be made suitable for large scale fermentation in low cost industrial medium. The first report of recombinant P(3HB) production experiments in fed-batch cultures used an expensive complex medium, producing P(3HB) to 90 g/L in 42 hours using a ph-stat controlled system (Kim, et al.,  Biotechnol. Lett.  14:811-16 (1992)). Using stabilized plasmids derived from either medium- or high-copy-number plasmids, it was shown that  E. coli  XL1-Blue with the latter type plasmid is required for substantial P(3HB) accumulation (Lee, et al.,  Ann. N.Y. Acad. Sci.  721:43-53 (1994)). In a fed-batch fermentation on 2% glucose/LB medium, this strain produced 81% P(3HB) at a productivity of 2.1 g/L-hr (Lee, et al.,  J. Biotechnol.  32:203-11 (1994)). The P(3HB) productivity was reduced to 0.46 g/L-hr in minimal medium, but could be recovered by the addition of complex nitrogen sources such as yeast extract, tryptone, casamino acids, and collagen hydrolysate (Lee &amp; Chang,  Adv. Biochem. Eng. Biotechnol.  52:27-58 (1995); Lee, et al.,  J. Ferment. Bioeng.  79:177-80 (1995)).  
           [0009]    Although recombinant  E. coli  XL1-blue is able to synthesize substantial levels of P(3HB), growth is impaired by dramatic filamentation of the cells, especially in defined medium (Lee, et al.,  Biotechnol. Bioeng.  44:1337-47 (1994); Lee,  Biotechnol. Lett.  16:1247-52 (1994); Wang &amp; Lee,  Appl. Environ. Microbiol.  63:4765-69 (1997)). By overexpression of FtsZ in this strain, biomass production was improved by 20% and P(3HB) levels were doubled (Lee &amp; Lee,  J. Environ. Polymer Degrad.  4:131-34 (1996)). This recombinant strain produced 104 g/L P(3HB) in defined medium corresponding to 70% of the cell dry weight. The volumetric productivity of 2 g/L-hr, however, is lower than achievable with  R. eutropha . Furthermore, about 15% of the cells lost their ability to produce PHB by the end of the fermentation (Wang &amp; Lee,  Biotechnol. Bioeng.  58:325-28 (1998)).  
           [0010]    Recombinant  E. coli  P(3HB-3HV) producers reportedly are unable to grow to a high density and therefore are unsuited for commercial processes (Yim, et al.,  Biotechnol. Bioeng.  49:495-503 (1996)). In an attempt to improve P(3HB-3HV) production in a recombinant strain, four  E. coli  strains (XL1-Blue, JM109, HB101, and DH5α) were tested by Yim et al. All four recombinant  E. coli  strains synthesized P(3HB-3HV) when grown on glucose and propionate with HV fractions of 7% (Yim, et al.,  Biotechnol. Bioeng.  49:495-503 (1996)). Unlike other strains studied (Slater, et al.,  Appl. Environ. Microbiol.  58:1089-94 (1992)), recombinant XL1-Blue incorporates less than 10% HV when the propionic acid concentration is varied between 0 and 80 mM. HV incorporation and PHA formation were increased by pre-growing cells on acetate followed by glucose/propionate addition at a cell density of around 10 8  cells per ml. Oleate supplementation also stimulated HV incorporation. This recombinant XL1-Blue when pregrown on acetate and with oleate supplementation reached a cell density of 8 g/L, 75% of which was P(3HB-3HV) with an HV fraction of 0.16 (Yim, et al.,  Biotechnol. Bioeng.  49:495-503 (1996)).  
           [0011]    One of the challenges of producing P(3HB) in recombinant organisms is the stable and constant expression of the phb genes during fermentation. Often P(3HB) production by recombinant organisms is hampered by the loss of plasmid from the majority of the bacterial population. Such stability problems may be attributed to the metabolic load exerted by the need to replicate the plasmid and synthesize P(3HB), which diverts acetyl-CoA to P(3HB) rather than to biomass. In addition, plasmid copy numbers often decrease upon continued fermentation because only a few copies provide the required antibiotic resistance or prevent cell death by maintaining parB. For these reasons, a runaway plasmid was designed to suppress the copy number of the plasmid at 30 C and induce plasmid replication by shifting the temperature to 38 C (Kidwell, et al.,  Appl. Environ. Microbiol.  61:1391-98 (1995)). Using this system, P(3HB) was produced to about 43% of the cell dry weight within 15 hours after induction with a volumetric production of 1 gram P(3HB) per liter per hour. Although this productivity is of the same order of magnitude as natural P(3HB) producers, strains harboring these parB-stabilized runaway replicons still lost the capacity to accumulate P(3HB) during prolonged fermentations.  
           [0012]    While the instability of the phb genes in high cell-density fermentations affects the PHA cost by decreasing the cellular P(3HB) yields, the cost of the feedstock also contributes to the comparatively high price of PHAs. The most common substrate used for P(3HB) production is glucose. Consequently,  E. coli  and Klebsiella strains have been examined for P(3HB) formation on molasses, which cost 33-50% less than glucose (Zhang, et al.,  Appl. Environ. Microbiol.  60:1198-1205 (1994)). The main carbon source in molasses is sucrose. Recombinant  E. coli  and  K. aerogenes  strains carrying the phb locus on a plasmid grown in minimal medium with 6% sugarcane molasses accumulated P(3HB) to approximately 3 g/L corresponding to 45% of the cell dry weight. When the  K. aerogenes  was grown fed-batch in a 10 L fermenter on molasses as the sole carbon source, P(3HB) was accumulated to 70% its cell dry weight, which corresponded to 24 g/L. Although the phb plasmid in  K. aerogenes  was unstable, this strain shows promise as a P(3HB) producer on molasses, especially since fadR mutants incorporate 3HV up to 55% in the presence of propionate (Zhang, et al.,  Appl. Environ. Microbiol.  60:1198-1205 (1994)).  
           [0013]    U.S. Pat. No. 5,334,520 to Dennis discloses the production of PHB in  E. coli  transformed with a plasmid containing the phbCAB genes. A rec − , lac +    E. coli  strain was grown on whey and reportedly accumulates PHB to 85% of its cell dry weight. U.S. Pat. No. 5,371,002 to Dennis et al. discloses methods to produce PHA in recombinant  E. coli  using a high copy number plasmid vector with phb genes in a host that expresses the acetate genes either by induction, constitutively, or from a plasmid. U.S. Pat. No. 5,512,456 to Dennis discloses a method for production and recovery of PHB from transformed  E. coli  strains. These  E. coli  strains are equipped with a vector containing the phb genes and a vector containing a lysozyme gene. High copy number plasmids or runaway replicons are used to improve productivity. The vectors are stabilized by parB or by supF/dnaB(am). Using such strains, a productivity of 1.7 g/L-hr was obtained corresponding to 46 g/L PHB in 25 hrs, after which the plasmid was increasingly lost by the microbial population. PCT WO94/21810 discloses the production of PHB in recombinant strains of  E. coli  and  Klebsiella aerogenes  with sucrose as a carbon source. PCT WO 95/21257 discloses the improved production of PHB in transformed prokaryotic hosts. Improvements in the transcription regulating sequences and ribosome binding site improve PHB formation by the plasmid based phb genes. The plasmid is stabilized by the parB locus. PHB production by this construct is doubled by including the 361 nucleotides that are found upstream of phbC in  R. eutropha  instead of only 78 nucleotides. It is generally believed that PHB production by recombinant microorganisms requires high levels of expression using stabilized plasmids. Since plasmids are available in the cell in multiple copies, ranging from one to several hundreds, the use of plasmids ensured the presence of multiple copies of the genes of interest. Since plasmids may be lost, stabilization functions are introduced. Such systems, which are described above, have been tested for PHB production, and the utility of these systems in industrial fermentation processes has been investigated. However, overall PHB yield is still affected by loss of phb genes.  
           [0014]    It is therefore an object of the present invention to provide recombinant microorganisms strains useful in industrial fermentation processes which can accumulate commercially significant levels of PHB while providing stable and constant expression of the phb genes during fermentation.  
           [0015]    It is another object of the present invention to provide transgenic microbial strains for enhanced production of poly(3-hydroxyalkanoates).  
           [0016]    It is another object of the present invention to provide transgenic microbial strains which yield stable and constant expression of the phb genes during fermentation and accumulate commercially significant levels of PHB, and methods of use thereof.  
         SUMMARY OF THE INVENTION  
         [0017]    Transgenic microbial strains are provided which contain the genes required for PHA formation integrated on the chromosome. The strains are advantageous in PHA production processes, because (1) no plasmids need to be maintained, generally obviating the required use of antibiotics or other stabilizing pressures, and (2) no plasmid loss occurs, thereby stabilizing the number of gene copies per cell throughout the fermentation process, resulting in homogeneous PHA product formation throughout the production process. Genes are integrated using standard techniques, preferably transposon mutagenesis. In a preferred embodiment wherein mutiple genes are incorporated, these are incorporated as an operon. Sequences are used to stabilize mRNA, to induce expression as a function of culture conditions (such as phosphate concentration), temperature, and stress, and to aid in selection, through the incorporation of selection markers such as markers conferring antibiotic resistance. 
       
    
    
     BRIEF DESCRIPTION OF THE DRAWINGS  
       [0018]    [0018]FIG. 1 is a diagram showing the construction of pMNXTp 1 kan, pMNXTp 1 cat, pMSXTp 1 kan, and pMSXTp 1 cat.  
         [0019]    [0019]FIG. 2 is a diagram showing the construction of pMUXC 5 cat.  
         [0020]    [0020]FIG. 3 is a diagram showing the construction of pMUXAB 5 cat, pMUXTp 1 AB 5 kan, pMUXTp 11 AB 5 kan, pMUXTp 12 AB 5 kan, and pMUXTp 13 AB 5 kan. 
     
    
     DETAILED DESCRIPTION OF THE INVENTION  
       [0021]    By randomly inserting genes that encode PHA biosynthetic enzymes into the chromosome of  E. coli , means have been identified to directly achieve high levels of expression from strong endogenous promoters at sites that are non-essential for growth of the host in industrial medium based fermentations. As demonstratd by the examples,  E. coli  strains have been obtained using these techniques that produce PHAs in levels exceeding 85% of the cell dry weight from single copy genes on the chromosome. Expression of the phb genes in these strains is not dependent on the upstream sequences of phbC in  R. eutropha  nor on a high copy number construct. Maintenance of the phb genes by these strains is independent of the supplementation of antibiotics, the presence of stabilizing loci such as parB or hok/sok or any other selective pressure. The ultra-high level of expression required in the plasmid-based systems has been found to be completely unnecessary. Furthermore, unlike the most successful fermentations reported to date (Wang &amp; Lee,  Biotechnol. Bioeng.  58:325-28 (1998)) for recombinant plasmid-based  E. coli , fermentation with these strains provides that virtually all of the cells contain PHB at the end of the fermentation.  
         [0022]    Despite the low copy number, these transgenic bacteria accumulate PHB to levels observed for wild-type organisms. The host used for recombinant PHB production also is an important parameter in designing a plasmid-based  E. coli  system. For example, although W3110 strains were poor PHB producers when using a plasmid-based system, it was found that by integrating the phb genes into the chromosome of this same host, the host retained excellent growth characteristics while accumulating commercially significant levels of PHB.  
         [0023]    Methods and Materials for Producing the Microbial Strains  
         [0024]    Bacterial Strains to be Modified  
         [0025]    A number of bacteria can be genetically engineered to produce polyhydroxyalkanoates. These include organisms that already produce polyhydroxyalkanoates, modified to utilize alternative substrates or incorporate additional monomers, or to increase production, and organisms that do not produce polyhydroxyalkanoates, but which expresses none to some of the enzymes required for production of polyhydroxylkanoates. Examples include  E. coli, Alcaligenes latus, Alcaligenese eutrophus , Azotobacter,  Pseudomonas putida , and  Ralstonia eutropha.    
         [0026]    Methods for Generating Transgenic PHB Producers  
         [0027]    Methods for incorporating engineered gene constructs into the chromosomal DNA of bacterial cells are well known to those skilled in the art. Typical integration mechanisms include homologous recombination using linearized DNA in recBC or recD strains followed by P1 transduction (Miller 1992, A Short Course in Bacterial Genetics: A laboratory manual &amp; Handbook for  Escherichia coli  and Related Bacteria. Cold Spring Harbor laboratory Press, Cold Spring Harbor, N.Y.) special plasmids (Hamilton et al.,  J. Bacteriol.  171:4617 (1989); Metcalf et al.,  Plasmid  35:1 (1996); U.S. Pat. No. 5,470,727 to Mascarenhas et al.), or by random insertion using transposon based systems (Herrero et al.  J. Bacteriol.  172:6557 (1990); Peredelchuk &amp; Bennett,  Gene  187:231 (1997); U.S. Pat. No. 5,595,889 to Richaud et al.; U.S. Pat. No. 5,102,797 to Tucker et al.). In general, the microbial strains containing an insertion are selected on the basis of an acquired antibiotic resistance gene that is supplied by the integrated construct. However, complementation of auxotrophic mutants can also be used.  
         [0028]    Expression of the genes of interest for chromosomal integration can be achieved by including a transcription activating sequence (promoter) in the DNA construct to be integrated. Site-directed, homologous recombination can be combined with amplification of expression of the genes of interest, as described by U.S. Pat. No. 5,00,000 to Ingram et al. Although mini-transposon systems have been used for a number of years, they have been designed such that the expression level of the integrated gene of interest is not modulated. Ingram, et al. selected for increased expression of a foreign gene inserted into the  E. coli  chromosome by homologous recombination. This was achieved by inserting a promoter-less chloroamphenicol (Cm) resistance gene downstream of the gene of interest to create a transcriptional fusion. After a transcriptional fusion of the alcohol dehydrogenase gene with a promoterless chloramphenicol acetyl transferase genes is integrated in the pfl gene, increased expression is achieved by selecting mutants on increasing concentrations of chloramphenicol. However, in chemostat studies these stabilzed strains still lost the capacity to produce ethanol (Lawford &amp; Rousseau,  Appl. Biochem. Biotechnol.  57-58:293-305 (1996)). Also, strains that contained the ethanologenic genes on the chromosome demonstrated a decreased growth rate in glucose minimal medium (Lawford &amp; Rousseau,  Appl. Biochem. Biotechnol.,  57-58:277-92 (1996)).  
         [0029]    These approaches have been combined and modified to randomly integrate a mini-transposon into the chromosome to select for healthy, fast growing transgenic strains coupled with a screening system for modulating expression of the integrated genes. A series of expression cassettes have been developed for inserting heterologous genes into bacterial chromosomes. These cassettes are based on the transposon delivery systems described by Herrero et al.,  J. Bacteriol.  172:6557-67 (1990); de Lorenzo et al.,  J. Bacteriol.  172:6568 (1990). Although these systems specify RP4-mediated conjugal transfer and use only transposon Tn10 and Tn5, any combination of transposon ends and delivery system could be adapted for the technology described, resulting in sustained and homogeneous PHA production.  
         [0030]    The following general approach is used for generating transgenic  E. coli  PHB producers: (1) a promoterless antibiotic resistance (abr) gene is cloned in the polylinker of a suitable plasmid such as pUC18NotI or pUC18SfiI so that the major part of the polylinker is upstream of abr; (2) phb genes are subsequently cloned upstream of and in the same orientation as the abr gene; (3) the phb-abr cassette is excised as a NotI or AvrII fragment (AvrII recognizes the SfiI site in pUC18SfiI) and cloned in the corresponding sites of any plasmid like those from the pUT- or pLOF-series; (4) the resulting plasmids are maintained in  E. coli  λpir strains and electroporated or conjugated into the  E. coli  strain of choice in which these plasmids do not replicate; and (5) new strains in which the phb-abr cassette has successfully integrated in the chromosome are selected on selective medium for the host (e.g., naladixic acid when the host is naladixic acid resistant) and for the cassette (e.g., chloramphenicol, kanamycin, tetracyclin, mercury chloride, bialaphos). The resulting phb integrants are screened on minimal medium in the presence of glucose for growth and PHB formation.  
         [0031]    Several modifications of this procedure can be made. If the promotorless antibiotic resistance marker is not used, the insertion of the PHA genes is selected based on a marker present in the vector and integrated strains producing the desired level of PHA are detected by screening for PHA production. The phb genes may have, but do not need, endogeneous transcription sequences, such as upstream activating sequences, RNA polymerase binding site, and/or operator sequences. If the phb genes do not have such sequences, the described approach is limited to the use of vectors like the pUT series in which transcription can proceed through the insertion sequences. This limitation is due to the inability of RNA polymerase to read through the Tn10 flanking regions of the pLOF plasmids. The abr gene may carry its own expression sequences if so desired. Instead of an abr gene, the construct may be designed such that an essential gene serves as selective marker when the host strain has a mutation in the corresponding wild-type gene. Examples of genes useful for this purpose are generally known in the art. Different constructs can be integrated into one host, either subsequently or simultaneously, as long as both constructs carry different marker genes. Using multiple integration events, phb genes can be integrated separately, e.g., the PHB polymerase gene is integrated first as a phbC-cat cassette, followed by integration of the thiolase and reductase genes as a phbAB-kan cassette. Alternatively, one cassette may contain all phb genes whereas another cassette contains only some phb genes required to produce a desired PHA polymer.  
         [0032]    In some cases a transposon integration vector such as pJMS11 (Panke et al. Appl. Enviro. Microbiol. 64: 748-751) may be used such that the selectable marker can be excised from the chromosome of the integrated strain. This is useful for a number of reasons including providing a mechanism to insert multiple transposon constructs using the same marker gene by excising the marker following each insertion event.  
         [0033]    Sources of phb and Other Genes Involved in PHA Formation  
         [0034]    A general reference is Madison and Huisman, 1999, Microbiology and Molecular Biology Reviews 63: 21-53. The phb genes may be derived from different sources and combined in a single organism, or from the same source.  
         [0035]    Thiolase Encoding Genes  
         [0036]    Thiolase encoding genes have been isolated from  Alcaligenes latus, Ralstonia eutropha  (Peoples &amp; Sinskey,  J. Biol. Chem.  264(26): 15298-303 (1989); Acinetobacter sp. (Schembri, et al.,  J. Bacteriol.  177(15):4501-7 (1995)),  Chromotium vinosum  (Liebergesell &amp; Steinbuchel,  Eur. J. Biochem.  209(1%:135-50 (1992)),  Pseudomonas acidophila, Pseudomonas denitrificans  (Yabutani, et al.,  FEMS Microbiol. Lett.  133 (1-2):85-90 (1995)),  Rhizobium meliloti  (Tombolini, et al.,  Microbiology  141:2553-59 (1995)),  Thiocystis violacea  (Liebergesell &amp; Steinbuchel,  Appl. Microbiol. Biotechnol.  38(4):493-501 (1993)), and  Zoogloea ramigera  (Peoples, et al.,  J. Biol. Chem.  262(1):97-102 (1987)).  
         [0037]    Other genes that have not been implicated in PHA formation but which share significant homology with the phb genes and/or the corresponding gene products may be used as well. Genes encoding thiolase- and reductase-like enzymes have been identified in a broad range of non-PHB producing bacteria.  E. coli  (U29581, D90851, D90777),  Haemophilus influenzae  (U32761),  Pseudomonas fragi  (D10390),  Pseudomonas aeruginosa  (U88653),  Clostridium acetobutylicum  (U08465),  Mycobacterium leprae  (U00014),  Mycobacterium tuberculosis  (Z73902),  Helicobacter pylori  (AE000582),  Thermoanaerobacterium thermosaccharolyticum  (Z92974),  Archaeoglobus fulgidus  (AE001021),  Fusobacterium nucleatum  (U37723),  Acinetobacter calcoaceticus  (L05770),  Bacillus subtilis  (D84432, Z99120, U29084), and Synechocystis sp. (D90910) all encode one or more thiolases from their chromosome. Eukaryotic organisms such as  Saccharomyces cerevisiae  (L20428),  Schizosaccharomyces pombe  (D89184),  Candida tropicalis  (D13470),  Caenorhabditis elegans  (U41105), human (S70154), rat (D13921), mouse (M35797), radish (X78116), pumpkin (D70895), and cucumber (X67696) also express proteins with significant homology to the 3-ketothiolase from  R. eutropha.    
         [0038]    Reductase Encoding Genes  
         [0039]    Reductase encoding genes have been isolated from  A. latus, R. eutropha  (Peoples &amp; Sinskey,  J. Biol. Chem.  264(26): 15298-303 (1989); Acinetobacter sp. (Schembri, et al.,  J. Bacteriol.  177(15):4501-7 (1995)),  C. vinosum  (Liebergesell &amp; Steinbuchel,  Eur. J. Biochem.  209(1):135-50 (1992)),  P. acidophila, P. denitrificans  (Yabutani, et al.,  FEMS Microbiol. Lett.  133 (1-2):85-90 (1995)),  R. meliloti  (Tombolini, et al.,  Microbiology  141:2553-59 (1995)), and  Z. ramigera  (Peoples, et al.,  J. Biol. Chem.  262(1):97-102 (1987)).  
         [0040]    Other genes that have not been implicated in PHA formation but which share significant homology with the phb genes and/or the corresponding gene products may be used as well. Genes with significant homology to the phbB gene encoding acetoacetyl CoA reductase have been isolated from several organisms, including  Azospirillum brasiliense  (X64772, X52913) Rhizobium sp. (U53327, Y00604),  E. coli  (D90745),  Vibrio harveyi  (U39441),  H. influenzae  (U32701),  B. subtilis  (U59433),  P. aeruginosa  (U91631), Synechocystis sp. (D90907),  H. pylori  (AE000570),  Arabidopsis thaliana  (X64464),  Cuphea lanceolata  (X64566) and  Mycobacterium smegmatis  (U66800).  
         [0041]    PHA Polymerase Encoding Genes  
         [0042]    PHA polymerase encoding genes have been isolated from  Aeromonas caviae  (Fukui &amp; Doi,  J. Bacteriol.  179(15):4821-30 (1997)),  A. latus, R. eutropha  (Peoples &amp; Sinskey,  J. Biol. Chem.  264(26):15298-303 (1989); Acinetobacter (Schembri, et al.,  J. Bacteriol.  177(15):4501-7 (1995)),  C. vinosum  (Liebergesell &amp; Steinbuchel,  Eur. J. Biochem.  209(1):135-50 (1992)),  Methylobacterium extorquens  (Valentin &amp; Steinbuchel,  Appl. Microbiol. Biotechnol.  39(3):309-17 (1993)),  Nocardia corallina  (GenBank Ace. No. AF019964),  Nocardia salmonicolor, P. acidophila, P. denitrificans  (Ueda, et al.,  J. Bacteriol.  178(3):774-79 (1996)),  Pseudomonas aeruginosa  (Timm &amp; Steinbuchel,  Eur. J. Biochem.  209(1):15-30 (1992)),  Pseudomonas oleovorans  (Huisman, et al.,  J. Biol. Chem.  266:2191-98 (1991)),  Rhizobium etli  (Cevallos, et al.,  J. Bacteriol.  178(6): 1646-54 (1996)),  R. meliloti  (Tombolini, et al.,  Microbiology  141 (Pt 10):2553-59 (1995)),  Rhodococcus ruber  (Pieper &amp; Steinbuchel,  FEMS Microbiol. Lett.  96(1):73-80 (1992)),  Rhodospirrilum rubrum  (Hustede, et al.,  FEMS Microbiol. Lett.  93:285-90 (1992)),  Rhodobacter sphaeroides  (Steinbuchel, et al.,  FEMS Microbiol. Rev.  9(2-4):217-30 (1992); Hustede, et al.,  Biotechnol. Lett.  15:709-14 (1993)), Synechocystis sp. (Kaneko,  DNA Res.  3(3): 109-36 (1996)),  T. violaceae  (Liebergesell &amp; Steinbuchel,  Appl. Microbiol. Biotechnol.  38(4:493-501 (1993)), and  Z. ramigera  (GenBank Acc. No. U66242).  
         [0043]    Vectors for Incorporation of Genes into the Bacterial Chromosomes  
         [0044]    The pUT and pLOF series of plasmid transposon delivery vectors useful in the PHA-producing methods described herein use the characteristics of transposon Tn5 and transposon Tn10, respectively. The transposase genes encoding the enzymes that facilitate transposition are positioned outside of the transposase recognition sequences&#39; and are consequently lost upon transposition. Both Tn5 and Tn10 are known to integrate randomly in the target genome, unlike, for example, the Tn7 transposon. However, generally any transposon can be modified to facilitate the insertion of heterologous genes, such as the phb genes, into bacterial genomes. This methodology thus is not restricted to the vectors used in the methods described herein.  
         [0045]    Methods and Materials for Screening for Enhanced Polymer Production  
         [0046]    Screening of Bacterial Strains  
         [0047]    The technology described above allows for the generation of new PHA producing strains and also provides new bacterial strains that are useful for screening purposes. Table 1 below shows the different combinations of chromosomally and plasmid encoded PHB enzymes and how specific strains can be used to identify new or improved enzymes.  
         [0048]    Besides a screening tool for genes that express improved enzymes,  E. coli  strains with a complete PHA pathway integrated on the chromosome can be used to screen for heterologous genes that affect PHA formation.  E. coli  is a useful host because genes are easily expressed from a multitude of plasmid vectors: high copy-number, low copy-number, chemical or heat inducible, etc. and mutagenesis procedures have been well established for this bacterium. In addition, the completely determined genomic sequence of  E. coli  facilitates the characterization of genes that affect PHA metabolism.  
         [0049]    Transgenic  E. coli  strains expressing an incomplete PHA pathway can be transformed with gene libraries to identify homologs of the missing gene from other organisms, either prokaryotic or eukaryotic. Because these screening strains do not have the complete PHA biosynthetic pathway, the missing functions can be complemented and identified by the ability of the host strain to synthesize PHA. Generally PHA synthesizing bacterial colonies are opaque on agar plates, whereas colonies that do not synthesize PHA appear translucent. Clones from a gene library that complement the missing gene confer a white phenotype to the host when grown on screening media. Generally screening media contains all essential nutrients with excess carbon source and an antibiotic for which resistance is specified by the vector used in the library construction.  
         [0050]    Besides new genes, genes encoding improved PHA biosynthetic enzymes can also be screened for. A mutagenized collection of plasmids containing a phb biosynthetic gene into an  E. coli  host strain lacking this activity but containing genes encoding the other PHA biosynthetic enzymes can be screened for increased or altered activity. For example, PHA polymerases with increased activity can be screened for in a strain that expresses thiolase and reductase from the chromosome by identifying PHB-containing colonies under conditions that support PHB formation poorly. mcl-PHA polymerases with an increased specificity towards C 4  can similarly be screened for under PHB accumulation promoting conditions. Altered activities in the phaG encoded ACP::CoA transferase can be screened for by expressing mutated versions of this gene in a phbC integrant and screening for PHB formation from short chain fatty acids. Enzymes that have increased activity under sub-optimal physical conditions (e.g., temperature, pH, osmolarity, and oxygen tension) can be screened for by growing the host under such conditions and supplying a collection of mutated versions of the desired gene on a plasmid. Reductase enzymes with specificity to medium side-chain 3-ketoacyl-CoA&#39;s, such as 3-ketohexanoyl-CoA, can be screened for by identifying PHA synthesizing colonies in a strain that has a msc-PHA polymerase gene integrated on the chromosome and mutagenized versions of a phbB gene on a plasmid. The combination of different specificity PHA enzymes allows for the screening of a multitude of new substrate specificities. Further permutations of growth conditions allows for screening of enzymes active under sub-optimal conditions or enzymes that are less inhibited by cellular cofactors, such as Coenzyme A and CoA-derivatives, reduced or oxidised nicotinamide adenine dinucleotide or nicotinamide adenine dinucleotide phosphate (NAD, NADP, NADH, and NADPH).  
         [0051]    Using the techniques described herein,  E. coli  strains expressing the genes encoding enzymes for the medium side-chain PHA pathway can be constructed. Strains in which either phaC or phaG or both are integrated on the chromosome of  E. coli  accumulate a PHA including medium chain-length 3-hydroxy fatty acids of which 3-hydroxydecanoate is the predominant constituent. When phaC is integrated by itself, msc-PHAs can be synthesized from fatty acids. In such strains, it is advantageous to manipulate fatty acid oxidation such that 3-hydroxy fatty acid precursors accumulate intracellularly. This manipulation can be achieved by mutagenesis or by substituting the  E. coli  fatty acid degradation enzymes FadA and FadB encoding genes with the corresponding faoAB genes from  Pseudomonas putida  or related rRNA homogy group I fluorescent pseudomonad.  
                                 TABLE 1                           Phenotypes of Strains for Screening of New or Improved Enzymes            Genes integrated   Gene(s) on   Carbon source   Screen identifies       on chromosome   plasmid   for screen   genes encoding               phbC   library   glucose   new thiolase/                   reductase           library   fatty acids   new reductase,                   hydratase, trans-                   ferase           library   hydroxy fatty acid,   hydroxy               e.g. 4-   fatty acid               hydroxybutyrate   activating               (4HB)   enzyme, e.g.                   4HB-CoA trans-                   ferase (acetyl-                   CoA or succinyl-                   CoA dependent)                   or 4HB-CoA                   synthase           phaG   glucose   transferase with                   new substrate                   specificity       phbAB   library   glucose   new polymerase                   gene           phaC   glucose; altered   polymerase with               environmental   new substrate               conditions   specificity;                   increased activity                   under sub-optimal                   conditions       phbBC   library   glucose   new thiolase           phbA   limiting glucose/less   deregulated               prefered carbon   thiolase;               sources or rich   increased               medium; altered   activity under               environmental   sub-optimal               conditions   conditions       phbAC   library   glucose   new reductase           phbB   limiting glucose/less   deregulated               prefered carbon   reductase;               sources or rich   increased activity               medium; altered   under sub-optimal               environmental   conditions               conditions       phbCAB   library   any   enzymes affecting                   PHB formation                   under specific                   conditions       phbCAB, random       any   enzymes affecting       mutations           PHB formation       (chemical or           under specific       transposon)           conditions       phaC   library   hexanoate   hydratase with                   specificity for                   C6 and longer                   substrates           phaJ   fatty acids   hydratase with                   increased                   specificity                   for C6 and longer                   substrates           phbB   fatty acids   reductase with                   new substrate                   specificity       phaC fadR + , Δato   phbAB   glucose + butyrate   thiolase/reductase                   combination                   specific                   for C6 monomer       phaJ   phaC   fatty acids   polymerase with                   wider substrate                   specificity       phaG   phbC   glucose   polymerase with                   wider substrate                   specificity                  
 
       EXAMPLES  
       [0052]    The methods and compositions described herein will be further understood by reference to the following non-limiting examples. These examples use the following general methods and materials.  
         [0053]    Materials and Methods  
         [0054]    [0054] E. coli  strains were grown in Luria-Bertani medium (Sambrook, et al.,  Molecular Cloning: A Laboratory Manual,  2d ed. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. [1992 at 37° C. or 30° C. or in minimal E2 medium (Lageveen et al.,  Appl. Environ. Microbiol  54: 2924-2932 (1988)). DNA manipulations were performed on plasmid and chromosomal DNA purified with the Qiagen plasmid preparation or Qiagen chromosomal DNA preparation kits according to manufacturers recommendations. DNA was digested using restriction enzymes (New England Biolabs, Beverly, Mass.) according to manufacturers recommendations. DNA fragments were isolated from 0.7% agarose-Tris/acetate/EDTA gels using a Qiagen kit.  
         [0055]    Plasmid DNA was introduced into  E. coli  cells by transformation or electroporation (Sambrook, et al.,  Molecular Cloning: A Laboratory Manual,  2d ed. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.)). Transposition of phb genes from the pUT vectors was achieved by mating of the plasmid donor strain and the recipient (Herrero et al.,  J. Bacteriol.  172:6557 (1990)). The recipient strains used were spontaneous naladixic acid or rifampicin resistant mutants of  E. coli  derived from either LS5218 or MBX23. MBX23 is LJ14 rpoS::Tn10 in which the rpoS::Tn10 allele was introduced by P1 transduction from strain 1106 (Eisenstark). Recipients in which phb genes have been integrated into the chromosome were selected on naladixic acid or rifampicin plates supplemented with the antibiotic resistance specified by the mini-transposon, kanamycin, or chloramphenicol. Oligonucleotides were purchased from Biosynthesis or Genesys. DNA sequences were determined by automated sequencing using a Perkin-Elmer ABI 373A sequencing machine. DNA was amplified using the polymerase-chain-reaction in 50 microliter volume using PCR-mix from Gibco-BRL (Gaithersburg, Md.) and an Ericomp DNA amplifying machine.  
         [0056]    DNA fragments were separated on 0.7% agarose/TAE gels. Southern blots were performed according to procedures described by Sambrook, et al.,  Molecular Cloning: A Laboratory Manual,  2d ed. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.). Detection of DNA fragments containing phb genes was performed using chemiluminescent labeling and detection kits from USB/Amersham. Proteins samples were denatured by incubation in a boiling water bath for 3 minutes in the presence of 2-mercaptoethanol and sodium dodecylsulphate and subsequently separated on 10%, 15%, or 10-20% sodium dodecylsulphate-polyacrylamide gels. After transfer of protein to supported nitrocellulose membranes (Gibco-BRL, Gaithersburg, Md.), 3-ketoacyl-CoA thiolase, acetoacetyl-CoA reductase and PHB polymerase was detected using polyclonal antibodies raised against these enzymes and horseradish peroxidase labeled secondary antibodies followed by chemiluminescent detection (USB/Amersham).  
         [0057]    Acetoacetyl-CoA thiolase and acetoacetyl-CoA reductase activities were determined as described by Peoples and Sinskey, J. Biol. Chem. 264: 15293-15297 (1989) in cell free extracts from strains grown for 16 hours in LB-medium at 37 C. The acetoacetyl-CoA thiolase activity is measured as degradation of a Mg 2+ -acetoacetyl-CoA complex by monitoring the decrease in absorbance at 304 m after addition of cell-free extract using a Hewlett-Packer spectrophotometer. The acetoacetyl-CoA reductase activity is measured by monitoring the conversion of NADH to NAD at 340 nm using a Hewlett-Packer spectrophotometer.  
         [0058]    Accumulated PHA was determined by gas chromatographic (GC) analysis as follows. About 20 mg of lyophilized cell mass was subjected to simultaneous extraction and butanolysis at 110 C for 3 hours in 2 mL of a mixture containing, by volume, 90% 1-butanol and 10% concentrated hydrochloric acid, with 2 mg/mL benzoic acid added as an internal standard. The water-soluble components of the resulting mixture were removed by extraction with 3 mL water. The organic phase (1 μL at a split ratio of 1:50 at an overall flow rate of 2 mL/min) was analyzed on an HP 5890 GC with FID detector (Hewlett-Packard Co, Palo Alto, Calif.) using an SPB-1 fused silica capillary GC column (30 m; 0.32 mm ID; 0.25 μm film; Supelco; Bellefonte, Pa.) with the following temperature profile: 80° C., 2 min.; 10° C. per min. to 250° C.; 250° C., 2 min. The standard used to test for the presence of 4-hydroxybutyrate units in the polymer was γ-butyrolactone, which, like poly(4-hydroxybutyrate), forms n-butyl 4-hydroxybutyrate upon butanolysis. The standard used to test for 3-hydroxybutyrate units in the polymer was purified PHB.  
         [0059]    The molecular weights of the polymers were determined following chloroform extraction by gel permeation chromatography (GPC) using a Waters Styragel HT6E column (Millipore Corp., Waters Chromatography Division, Milford, Mass.) calibrated versus polystyrene samples of narrow polydispersity. Samples were dissolved in chloroform at 1 mg/mL, and 50 μL samples were injected and eluted at 1 mL/min. Detection was performed using a differential refractometer.  
         [0060]    1-Methyl-3-nitro-1-nitroso-guanidine (NTG) mutagenesis was performed as described by Miller,  A Short Course in Bacterial Genetics  (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.) using a 90 minute treatment with 1 mg/ml NTG corresponding to 99% killing.  
       Example 1  
     Host Strains and Plasmid Tools for Gene Integration  
       [0061]    Strains and plasmids from which transposon vectors and transposon derivatives were developed are listed in Tables 2 and 3 below. MBX245 and MBX247 were selected by growing MBX23 and LS5218 respectively on LB plates containing approximately 30 g/ml naladixic acid. MBX246 and MBX248 were selected by growing MBX23 and LS5218, respectively, on LB plates containing 50 g/ml rifampicin. Colonies that appeared on these selective media within 24 hours were replica plated on the same medium and after growth stored in 15% glycerol/nutrient broth at −80° C.  
         [0062]    MBX245 and MBX247 were selected by growing MBX23 and LS5218 respectively on LB plates containing 30 μg/ml naladixic acid. MBX246 and MBX248 were selected by growing MBX23 and LS5218 respectively on LB plates containing 50 μg/ml rifampicin. Colonies that appeared on these selective media within 24 hours were replica plated on the same medium and after growth stored in 15% glycerol/nutrient broth at −80° C.  
                             TABLE 2                           Host Strains Used For Gene Integration            strain   genotype   source               DH5α   recA1 endA1 gyrA96 thi   1           hsdR17 supE44 relA1 Δ(lac-           proAB) (Φ80dlacΔ(lacZ)M15)       S17-1 λpir   recA thi pro hsdR − M +  RP4:2-   2           Tc::Mu::Km Tn7 λpir lysogen       CC118 λpir   Δ(ara-leu) araD ΔlacX74 galE   2           galK phoA20 thi-1 rpsE rpoB           argE(Am) recA1, λpir lysogen       XL1-Blue   F′::Tn10 lacI q  Δ(lacZ) M15   3           proAB/recA1 endA1 gyrA96           thi hsdR17 supE44 relA1 Δ(lac-           proAB)       LS5218   fadR601 atoC512 c     Spratt et al, 1981               J. Bacteriol. 146:               1166-1169       LJ14   LS5218 atoC2 c  atoA14   Spratt et al, 1981               J. Bacteriol. 146:               1166-1169       MBX23   LJ14 rpoS   Metabolix, Inc.       MBX245   MBX23 Nl r     Metabolix, Inc.       MBX246   MBX23 Rf r     Metabolix, Inc.       MBX247   LS5218 Nl r     Metabolix, Inc.       MBX248   LS5218 Rf r     Metabolix, Inc.                                          
 
         [0063]    [0063]                             TABLE 3                           Plasmids Used For Gene Integration            plasmid   characteristics   source               pUC18Not   Ap r , NotI sites flanking polylinker   2       pUC18Sfi   Ap r , SfiI sites flanking polylinker   2       pUTkan   Ap r , Km r , oriR6K, mobRP4   2           depends on λpir for replication       pUTHg   Ap r , Hg r , oriR6K, mobRP4   2           depends on λpir for replication       pKPS4   Ap r , phaC1 from  Pseudomonas               oleovorans         pUCDBK1   Ap r , phbA and phbB from   Peoples and Sinskey             Zoogloea ramigera     1989, Molecular               Microbiol.3: 349-357       pZS   Ap r , phbC from   WO 99/14313             Zoogloea ramigera                      
       Example 2  
     Construction of Cloning Vectors to Facilitate Integration of phb Genes  
       [0064]    The plasmids pMNXTp1kan and pMNXTp1cat were based on the plasmids pUC18Not and pUC18Sfi and developed as shown in FIG. 1.  
         [0065]    The Tn903 kanamycin (Km) resistance gene from plasmid pBGS18 was amplified by PCR using the oligonucleotide primers linkK1,  
         [0066]    5′ TGCATGCGATATCAATTGTCCA GCCAGAAAGTGAGG,  
         [0067]    and linkK2,  
         [0068]    5′ ATTTATTCAACAAAGCCGCC.  
         [0069]    Prior to PCR amplification, the primers were phosphorylated using T4 polynucleotide kinase using standard procedures. The DNa was amplified using the following program: 1 cycle of 3 min at 95° C., 40 s at 42° C., 2 min at 72° C., followed by 30 cycles of 40 s at 95° C., 40 s at 42° C. and 90 s at 72° C. The DNA then was phenol extracted and treated with T4 DNA polymerase prior to gel purification. The blunt ended 0.8 kb DNA fragment was then inserted into the Ecl136II site in the polylinker of pUC18Not to obtain pMNXkan.  
         [0070]    The cat gene was obtained as an HindIII cassette from Pharmacia (Pharmacia Inc. NJ), blunt ended using Klenow fragment of DNA polymerase, and inserted into the Ecl136II site of pUC18Not to obtain pMNXcat.  
         [0071]    The trp terminator sequence was constructed by annealing the two synthetic oligonucleotides TERM1  
         [0072]    (5′ CCCAGCCCGCTAATGAGCGGGCTTTTTTTTGAACAA AA 3′)  
         [0073]    and TERM2  
         [0074]    (5′ TACGTATTTTGTTCAAAAAAAAGCCCGCTCATTAGCGGG CTGGG 3′).  
         [0075]    The terminator was then inserted into the HindIII-SphI site of pMNXkan and pMNXcat to obtain pMNXTkan and pMNXTcat, respectively. These vectors were constructed such that any promoter fragment can be added between the SphI and Sac sites. Promoter p, was constructed by annealing of the synthetic oligonucleotides PHBB1  
         [0076]    (5′ TACGTACCCCAGGCTTTACATTTATGCTTCCGGCTCGTATGTTGT GTGGAATTG TGAGCGGTT 3′)  
         [0077]    and PHBB2  
         [0078]    (5′ TTCGAACCGCTCACAATTCCACACAACATACGAGCCGGAAGC ATAAATGTAAAGCCTGGGG3′)  
         [0079]    followed by filling in the ends with Klenow fragment of DNA polymerase. The blunt-ended promoter fragment p, was then inserted into the HincII site of pMNXTkan and pMNXTcat to obtain pMNXTp 1 kan and pMNXTp 1 cat, respectively.  
         [0080]    Plasmid pMSXTp 1 cat was constructed by transferring the Tp 1 cat cassette from pMNXTp 1 cat as an EcoRI-HindIII fragment into the EcoRI-HindIII site of pUC18Sfi. Similarly, pMSXTp 1 kan was constructed by transferring the EcoRI-HindIII fragment containing Tp 1 kan into the EcoRI-HindIII site of pUC18Sfi.  
       Example 3  
     Construction of Plasmids for Chromosomal Integration of phbC, Encoding PHB Polymerase  
       [0081]    Plasmid pMUXC 5 cat contains the phbC gene from  Z. ramigera  on a transposable element for integration of this gene on the chromosome of a recipient strain, as shown in FIG. 2. Strong translational sequences were obtained from pKPS4 which includes phaC1 encoding PHA polymerase from  P. oleovorans  in the pTrc vector (Pharmacia). In this construct, phaC1 is preceded by a strong ribosome binding site: AGGAGGTTTTT(-ATG). The phaC1 gene including the upstream sequences, was cloned as a blunt ended EcoRI-HindIII fragment in the SmaI site of pUC18Sfi to give pMSXC 3 . A blunt ended cat gene cassette was subsequently cloned in the blunt-ended Sse8387II site, resulting in pMSXC 3 cat. At this point, all of the phaC1 coding region except the 5′ 27 base pairs were removed as a PstI-BamHI fragment and replaced by the corresponding fragment from the phbC gene from  Z. ramigera . The resulting plasmid pMSXC 3 cat encodes a hybrid PHB polymerase enzyme with the 9 amino terminal residues derived from the  P. oleovorans  PHA polymerase and the remainder from  Z. ramigera . The C 5 cat cassette was then excised as an AvrII fragment and cloned in the corresponding sites of pUTHg, thereby deleting the mercury resistance marker from this vector. The resulting plasmid, pMUXC 5 cat, contains a C 5 cat mini-transposon in which phbC is not preceded by a promoter sequence. Expression of the cassette upon integration is therefore dependent on transcriptional sequences that are provided by the DNA adjacent to the integration site.  
       Example 4  
     Construction of Plasmids for Chromosomal Integration of phbAB, Encoding Thiolase and Reductase  
       [0082]    pMSXTp 1 AB 5 kan2 was constructed from pMSXTp 1 kan as partially shown in FIG. 3. First pMSXTp 1 kan was digested with NdeI, filled in with Klenow and religated to obtain pMSXTp 1 kan2 in which the NdeI site is deleted. This deletion results in a unique NdeI site just upstream of phbA of  Z. ramigera  during later stages of the cloning procedure.  
         [0083]    B 5  was cloned as a NarI fragment from pUCDBK1 (Peoples and Sinskey 1989, Molecular Microbiol. 3: 349-357) and cloned in the HincII site of pUC18Sfi to generate pMSXB 5 . A 5  was inserted as an FseI/blunt-SalI fragment in the Ecl36II-SalI sites resulting in pMSXAB 5  and regenerating the  Z. ramigera  AB 5  intergenic region. pMSXAB 5 cat was created by inserting a promoterless cat cassette in the HindIII site of pMSXAB 5 . The AB 5  fragment from pMSXAB 5 cat was cloned as a EcoRI-PstI fragment into the SmaI site of pMSXTp 1 kan2 giving pMSXTp 1 AB 5 kan2.  
         [0084]    The expression cassette AB 5 cat was then excised as a 2.8 kb AvrII fragment and ligated into the AvrII site of pUTHg and transformed into  E. coli  strain CC118 λpir to obtain plasmid pMUXAB 5 cat. This plasmid was then transformed into  E. coli  S17-1λpir and used to insert the AB5cat expression cassette into the chromosome of  E. coli  MBX247 by conjugation. The resulting Ap s /Cm r  transconjugants were characterized for integration and expression of the thiolase and reductase genes encoded by the phbAB genes.  
       Example 5  
     Construction of Plasmids with Improved Promoters for Integration of phbAB into the Chromosome of  E. coli    
       [0085]    Expression of phbAB5 was improved by introduction of strong promoters upstream of these genes, as shown in FIG. 3. These promoters were generated with sets of oligonucleotides that provide upstream activating sequences, a −35 promoter region, a −10 promoter region with transcriptional start site(s), and mRNA sequences with possible stabilizing functions. Plasmid pMSXTp 1 AB 5 kan2 was digested with PstI/XbaI, and a fragment containing the −10 region of the lac promoter was inserted as a fragment obtained after annealing oligonucleotides 3A  
         [0086]    (5′ GGCTCGTATAATGTGTGGAGGGAGAACCGCCGGGCTCGCGCCGTT)  
         [0087]    and 3B  
         [0088]    (5′ CTAGAACGGCGCGAGCCCGGCGGTTCTCCCTCCACACATTATAC GAGCCTGCA).  
         [0089]    Next, a fragment containing the lac −35 region and the rrnB region were inserted into the PstI site as a fragment obtained after annealing the oligonucleotides:  
                           1A           (5′ TTCAGAAAATTATTTTAAATTTCCTCTTGACATTTATGCT GCA)               and 1B       (5′ GCATAAATGTCAAGAGGAAATTTAAAATAATTTTCTGAATGCA).          
 
         [0090]    Next, the messenger stabilizing sequence including the transcriptional start site from AB 5  was inserted into the XbaI-NdeI sites as a fragment obtained after annealing the oligonucleotides:  
                           4A           (5′ CTAGTGCCGGACCCGGTTCCAAGGCCGGCCGCAAGGCTGCCAGAAC       TGAGGAAGCACA)               and 4B       (5′ TATGTGCTTCCTCAGTTCTGGCAGCCTTGCGGCCGGCCTTGGAACC       GGGTCCGGCA).          
 
         [0091]    The resulting plasmid is pMSXp 11 AB 5 kan2. The AvrII fragment, containing Tp 11 AB 5 kan2 was cloned into pUTHg cut with AvrII and used for integration into the genome of MBX379 and MBX245.  
         [0092]    Plasmid pMSXTp 12 AB 5 kan2 was constructed as pMSXTP 11 AB 5 kan2 with the distinction that the following oligonucleotides were used instead of oligonucleotides 1A and 1B:  
                                       2A:               (5′ TCCCCTGTCATAAAGTTGTCACTGCA)                       and 2B           (5′ GTGACAACTTTATGACAG GGGATGCA).          
 
         [0093]    These oligonucleotides provide a consensus  E. coli  pho box and −35 promoter region to generate a promoter that is potentially regulated by the phosphate concentration in the medium.  
         [0094]    pMSXTp 13 AB 5 kan2 was constructed to provide expression of AB 5  from a promoter that has been shown to be expressed under general stress conditions such as nutrient limitation, pH or heat shock, and administration of toxic chemicals. The promoter region of uspA was amplified using oligonucleotides  
                                       UspUp               (5′ TGACCAACATACGA GCGGC)                       and UspDwn           (5′ CTACCAGAACTTTGCTTTCC)          
 
         [0095]    in a PCR reaction consisting of an incubation at 95 C for 3 min. followed by 30 cycles of 40 s at 95° C., 40 s at 42° C., an incubation for 7 min. at 68° C., and final storage at 4° C. The approximately 350 bp PCR product was cloned into pCR2.1 (Invitrogen Corp., USA) to generate pMBXp 13 . An approximately 190 bp HincII-MscI fragment containing the promoter and transcriptional start site for uspA and the first 93 bp of the uspA mRNA was cloned into blunt ended BamHI-Sse8387I pMSXTp 1 kan2 to give pMSXTp 13 kan2. Plasmid pMSXTp 13 kan2 was then KpnI digested, blunt ended with T4 polymerase and dephosphorylated using calf intestinal phosphatase. The AB 5  genes were isolated as a 2.0 kb EcoRI/Sse8387I fragment from pMSXAB 5 , blunt ended using Klenow and T4 polymerase and ligated into the KpnI site of pMSXTp 13 kan2. In the resulting plasmid pMSXTp 13 AB 5 kan2, the phbAB and kan genes are expressed from the uspA (p 13 ) promoter.  
         [0096]    The p n AB 5 kan (n=11, 12, 13) expression cassettes were then excised as 2.8 kb AvrII fragments and ligated into the AvrII site of pUTHg and transformed into  E. coli  strain CC118 λpir to obtain plasmid pMUXp n AB 5 kan. This plasmid was then transformed into  E. coli  S17-1λpir and used to insert p 11 AB 5 kan, p 12 AB 5 kan, and p 13 AB 5 kan expression cassettes into the chromosome of  E. coli  strains by conjugation.  
       Example 6  
     Integration of C 5 cat into the Chromosome of  E. coli    
       [0097]    C 5 cat was introduced into the chromosome of MBX23 by conjugation using S17-1 λpir (pMUXC 5 cat) as the donor strain. The conjugation mixture was spread on LB/N1/Cm plates and integrants were obtained, 40% of which were sensitive to ampicillin, indicating that no plasmid was present in these strains. Five integrants were transformed with pMSXAB 5 cat (Ap r ) and grown on LB/Ap/Cm/2% glucose to examine biosynthetic activity of PHB polymerase (Table 4).  
                                 TABLE 4                           Integrated Strains                strain containing       strain after       strain   pMSXAB5cat   PHB phenotype   plasmid curing               MBX300   MBX305   ++++   MBX325       MBX301   MBX308   +++   MBX331       MBX302   MBX310   ++++   MBX326       MBX303   MBX315   ++++   MBX327       MBX304   MBX316   +   MBX337                  
 
       Example 7  
     Amplification of C5 Expression in Integrated Strains  
       [0098]    Expression of PHB polymerase was increased by restreaking MBX326 successively on LB plates containing 100, 200, 500, and 1000 μg/ml chloroamphenicol. Strain MBX379 was derived from MBX326 and exhibited chloramphenicol resistance up to 1000 μg/ml. In Southern blot analysis of chromosomal DNA isolated from MBX379 and its predecessors, the phbC5 copy-number had not increased. Western blot analysis indicated a strong increase in PHB polymerase levels in cell free extracts of these strains when the phbAB genes were present on a plasmid.  
       Example 8  
     Integration of p 11 AB 5 kan, p 12 AB 5 kan and p 13 AB 5 kan into MBX379  
       [0099]    S17-1 λpir strains with either pMUXp 11 AB 5 kan, pMUXp 12 AB 5 kan, or pMUXp 13 AB 5 kan were mated with MBX379. Transgenic strains in which phbAB 5 kan had integrated on the chromosome were selected on LB/N1/Km plates. Among the integrants, PHB producers were identified on LB/glucose plates. Representatives of the individual constructs were MBX612 (MBX379::p 11 AB 5 kan), MBX677 (MBX379:: p 12 AB 5 kan), and MBX680 (MBX379::p 13 AB 5 kan). Southern blots and Western blots showed that the phbAB genes had integrated in the chromosome and were expressed in these strains as well. Table 5 shows the PHB accumulation levels of transgenic  E. coli  PHB producers grown in Luria-Bertani medium with 2% glucose or minimal E2 medium with 2% glucose and 0.5% corn steep liquor.  
                                               TABLE 5                           PHB Accumulation Levels for Transgenic  E. coli  PUB Producers                % PHB of cell dry weight                    strain   LB/glucose   E2 glucose                       MBX612   56   35           MBX677   58   38           MBX680   39   50                      
 
       Example 9  
     Selection and Bacteriophage P1 Transduction to Yield Improved Strains  
       [0100]    The growth characteristics of MBX612, 677, and 680 were improved by bacteriophage P1 transduction. A single transduction step was required to transduce the C 5 cat and AB 5 kan alleles from the different strains into LS5218, indicating that the two separate integration cassettes were located close to each other on the chromosome. The resulting strains are MBX690 (from MBX681), MBX691 (from MBX677), and MBX698 (from MBX680). Repeated inoculation of MBX612 on minimal E2 medium with limiting nitrogen resulted in MBX681. Unlike the strains generated by P1 transduction, MBX681 did not exhibit improved growth characteristics. Southern blots and Western blots show that phbC and the phbAB genes were successfully transduced and were expressed in these strains as well. Table 6 below shows PHB accumulation levels for these transgenic  E. coli  PHB producers grown in Luria-Bertani medium with 2% glucose or minimal E2 medium with 2% glucose and 0.5% corn steep liquor.  
                                               TABLE 6                           PHB Accumulation Levels for Transgenic  E. coli  PHB Producers                % PHB of cell dry weight                    strain   LB/glucose   E2 glucose                       MBX681   54   22           MBX690   52   44           MBX691   54   28           MBX698   37   15                      
 
       Example 10  
     Further Improvements of Transgenic  E. coli  Strains for PHB Production  
       [0101]    Mutagenesis using NTG or EMS was used to further improve PHB production in MBX680. Strains MBX769 and MBX777 were selected after treatment of MBX680 with EMS and NTG, respectively. These strains were found to be able to grow on R2-medium supplied with 1% glucose, 0.5% corn steep liquor, and 1 mg/ml chloroamphenicol. MBX769 was grown in 50 ml R-10 medium/0.5% CSL with 2 or 3% glucose at 37° C. for 20 to 26 hours. PHB was accumulated to 71% of the cell dry weight. Similarly, MBX769 was grown in 50 ml LB with or without 0.375 g/L KH 2 PO 4 , 0.875 K 2 HPO 4 , 0.25 (NH 4 ) 2 SO 4 , and a total of 50 g/L glucose (five aliquots were added over the course of the incubation). After 63 hours of incubation, PHB had accumulated up to 96% of the cell dry weight.  
         [0102]    The phbC and phbAB alleles from MBX777 were subsequently transduced into LS5218, resulting in MBX820. Southern blots and Western blots show that phbC and the phbAB genes were successfully transduced and were expressed in these strains as well. Table 7 shows the PHB accumulation levels of these transgenic  E. coli  PHB producers grown in Luria-Bertani medium with 2% glucose or minimal E2 medium with 2% glucose and 0.5% corn steep liquor.  
                                               TABLE 7                           PHB Accumulation Levels for Transgenic  E. coli  PHB Producers                % PHB of cell dry weight                    strain   LB/glucose   E2 glucose                       MBX680   39   50           MBX777   67   57           MBX820   53   50                      
 
       Example 11  
     Growth Characteristics of Transgenic  E. coli  PHB Producers  
       [0103]    The introduction of phb genes into MBX245 (t d =47 min.) was accompanied by a reduction in growth rate (MBX680, t d =71 min.). Improved PHB production was achieved by EMS mutagenesis, but did not improve the growth rate (MBX777, t d =72 min.). P1 transduction of the PHB genes into a wild-type strain (MBX184) resulted in the same high growth rate as exhibited by MBX245 and PHB accumulation up to 50% of the cell dry weight in less than 24 hours (MBX820, t d =45 min.).  
       Example 12  
     Plasmids for Chromosomal Integration of Other pha Genes  
       [0104]    The integration of phbC, phbA, and phbB from  Z. ramigera  described herein also is applicable to other pha genes, such as genes encoding PHB polymerase from  R. eutropha  (C 1 ), PHA polymerase from  P. oleovorans  (C3), PHB polymerase from  A. caviae  (C 12), ACP::CoA transacylase from  P. putida  (G3), (R)-specific enouyl-CoA hydratase from  A. caviae  (J12), a broad substrate specific 3-ketoacyl-CoA thiolase from  R. eutropha  (A1-II), or a phasin from  R. eutropha  (P1-I and P1-II). These genes were obtained by polymerase chain reaction amplification using the following primers:  
                           C1 up           5′ g-GAATTC-aggaggtttt-       ATGGCGACCGGCAAAGGCGCGGCAG 3′               C1 dw       5′ GC-TCTAGA-AGCTT-tcatgccttggctttgacgtatcgc 3′               C3 up       5′ g-GAATTC-aggaggtttt-       ATGAGTAACAAGAACAACGATGAGC 3′               C3 dw       5′ GC-TCTAGA-AGCTT-tcaacgctcgtgaacgtaggtgccc 3′.               C12 up       5′ g-GAATTC-aggaggtttt-       ATGAGCCAACCATCTTATGGCCCGC 3′               C12 dw       5′ GC-TCTAGA-AGCTT-TCATGCGGCGTCCTCCTCTGTTGGG 3′               G3 up       5′ g-GAATTC-aggaggtttt-       ATGAGGCCAGAAATCGCTGTACTTG 3′               G3 dw       5′ GC-TCTAGA-AGCTT-tcagatggcaaatgcatgctgcccc 3′               J12 up       5′ ag-GAGCTC-aggaggtttt-       ATGAGCGCACAATCCCTGGAAGTAG 3′               J12 dw       5′ GC-TCTAGA-AGCTT-ttaaggcagcttgaccacggcttcc 3′               A1-II up       5′ g-GAATTC-aggaggtttt-       ATGACGCGTGAAGTGGTAGTGGTAAG 3′               A1-II dw       5′ GC-TCTAGA-AGCTT-tcagatacgctcgaagatggcggc 3′.               P1-I up       5′ g-GAATTC-aggaggtttt-       ATGATCCTCACCCCGGAACAAGTTG 3′               P1-I dw       5′ GC-TCTAGA-AGCTT-tcagggcactaccttcatcgttggc 3′               P1-II up       5′ g-GAATTC-aggaggtttt-       ATGATCCTCACCCCGGAACAAGTTG 3′               P1-II dw       5′ GC-TCTAGA-AGCTT-tcaggcagccgtcgtcttctttgcc 3′          
 
         [0105]    PCR reactions included 10 pmol of each primer, 1 to 5 μl of chromosomal DNA or boiled cells, and 45 μl PCR mix from Gibco BRL (Gaithersburg, Md.). Amplification was by 30 cycles of 60 s incubation at 94 C, 60 s incubation at a temperature between 45 C and 68 C and 1 to 3 minutes incubation at 72 C. PCR products were purified, digested with EcoRI and HindIII, blunt ended with the Klenow fragment of DNA polymerase, and cloned in the SmaI site of pMSXcat, pMSXkan, pMNXcat, or pMNXkan according to the schemes shown in FIGS. 1 and 2. pMUXpha was derived from pUTHg or pUTkan; and pMLXpha was derived from pLOFHg, where pha stands for the pha gene of choice. These plasmids were used for integration of the desired pha gene into the chromosome of  E. coli  or any other Gram-negative microbial strain suitable for PHA production  
       Example 13  
     PHBV Copolymer Producing Transgenic  E. coli  Strains  
       [0106]    [0106] E. coli  strains with chromosomally integrated phb genes such as described above also can be used to produce PHBV copolymers. PHBV is generally synthesized in fermentation systems where propionic acid is co-fed with glucose or other carbohydrate. After uptake, propionate is converted to propionyl-CoA, which by the action of acyl-CoA thiolase and 3-ketoacyl-CoA reductase is converted to 3-hydroxyvaleryl-CoA (3HV-CoA). 3HV-CoA is subsequently polymerized by PHA polymerase.  
         [0107]    The capacity to accumulate PHBV can be increased by increasing levels of enzymes that specifically synthesize HV monomers. Such enzymes may be involved in the uptake of propionic acid, in the activation of propionic acid to propionyl-CoA or in any of the PHB biosynthetic enzymes. Additionally, alternative enzymes can be isolated from other sources, or propionyl-CoA can be obtained from alternative pathways, e.g. from the methylmalonyl-CoA pathway. In this pathway, succinyl-CoA is converted to methylmalonyl-CoA which is then decarboxylated to yield propionyl-CoA.  
       Example 14  
     PHB-4HB Copolymer Producing Transgenic  E. coli  Strains  
       [0108]    Homopolymers and copolymers containing 4HB monomers can be produced by transgenic  E. coli  strains. Incorporation of 4HB from 4HB-CoA can be achieved by feeding 4-hydroxybutyrate to the PHA producing organisms. 4HB is activated to 4HB-CoA either through a 4-hydroxybutyryl-CoA transferase such as hbcT (OrfZ) from  Clostridium kluyveri  or by an endogenous  E. coli  enzyme or by any other enzyme with this capability. A P4HB homopolymer is produced when the transgenic  E. coli  strain contains only the phbC gene. 4HB containing copolymers can be synthesized when the transgenic  E. coli  strain contains genes encoding the complete PHB biosynthetic pathway.  
         [0109]    [0109] E. coli  MBX821 (LS5218::C 5 -cat 379 , atoC c ) was grown in Luria-Bertani medium and resuspended in 100 ml 10% LB with 5 g/L 4HB and 2 g/L glucose. After incubation of this culture for 24 hours, PHA was characterized and identified as containing only 4HB monomers. Similarly,  E. coli  MBX777 with a plasmid containing hbcT such as pFS16, was grown in LB/4HB (5 μL) and the resuting polymer was identified as PHB4HB with 35.5% 4HB monomers.  
       Example 15  
     Production of poly(4-hydroxybutyrate) from 4-hydroxybutyrate in Recombinant  E. coli  with No Extrachromosomal DNA  
       [0110]    Poly(4-hydroxybutyrate) can be synthesized from 4-hydroxybutyrate by  E. coli  expressing 4-hydroxybutyryl-CoA transferase (hbcT) and PHA synthase (phaC) genes from a plasmid. If these genes are integrated into the  E. coli  chromosome and expressed at high levels, the recombinant  E. coli  should be able to synthesize poly(4-hydroxybutyrate) from 4-hydroxybutyrate. The hbcT and phbC genes were inserted into pUTHg (Herrero, et al., J. Bacteriol. 172:6557-67, 1990) as follows. pMSXC 5 cat and pFS16 were both digested with BamHI and SalI. The large fragment of pMSXC 5 cat and the fragment of pFS16 containing the hbcT gene thus obtained were ligated together using T4 DNA ligase to form pMSXC 5 hbcT-cat. The fragment containing the phaC, hbcT, and cat genes was removed from pMSXC 5 hbcT-cat by digestion with AvrII, and it was inserted using T4 DNA ligase into pUTHg that had been digested with AvrII and treated with calf intestinal alkaline phosphatase to prevent self-ligation. The plasmid thus obtained was denoted pMUXC 5 hbcT-cat. The plasmid pMUXC 5 hbcT-cat was replicated in MBX129 and conjugated into MBX1177. The strain MBX1177 is a spontaneous mutant of  E. coli  strain DH5α that was selected for its ability to grow on minimal 4-hydroxybutyrate agar plates. MBX1177 is also naturally resistant to nalidixic acid. The recipient cells were separated from the donor cells by plating on LB-agar supplemented with 25 μg/mL chloramphenicol and 30 μg/mL nalidixic acid. Survivors from this plate were restreaked on minimal medium, containing, per liter: 15 g agar; 2.5 g/L LB powder (Difco; Detroit, Mich.); 5 g glucose; 10 g 4-hydroxybutyrate; 1 mmol MgSO 4 ; 10 mg thiamine; 0.23 g proline; 25.5 mmol Na 2 HPO 4 ; 33.3 mmol K 2 HPO 4 ; 27.2 mmol KH 2 PO 4 ; 2.78 mg FeSO 4 .7H 2 O; 1.98 mg MnCl 2 .4H 2 O; 2.81 mg CoSO 4 .7H 2 O; 0.17 mg CuCl 2 .2H 2 O; 1.67 mg CaCl 2 .2H 2 O; 0.29 mg ZnSO 4 .7H 2 O; and 0.5 mg chloramphenicol. Colonies from this plate that appeared to be especially white and opaque were evaluated in shake flasks containing the same medium as above except without agar. The individual colonies were first grown in 3 mL of LB medium for 8 hours, and 0.5 mL of each culture was used to inoculate 50 mL of the medium described above. These flasks were incubated at 30° C. for 96 hours. One isolate was found by GC analysis (for which the cells were removed from the medium by centrifugation for 10 minutes at 2000×g, washed once with water and centrifuged again, then lyophilized) to contain 4.9% poly(4-hydroxybutate) by weight. This strain was denoted MBX1462 and selected for further manipulations. MBX1462 was treated with the mutagen 1-methyl-3-nitro-1-nitrosoguanidine (MNNG), a chemical mutagen, by exposing a liquid culture of MBX1462 to 0.1 mg/mL MNNG for 90 minutes. It was found that 99.8% of the cells were killed by this treatment. The plating and shake flask experiment described above was repeated, and one isolate was found by GC analysis to contain 11% poly(4-hydroxybutate) by weight. This strain was denoted MBX1476 and selected for further manipulations. The NTG treatment was repeated and killed 96.3% of the cells. The plating and shake flask experiment described above was repeated once again, and one isolate was found by GC analysis to contain 19% poly(4-hydroxybutate) by weight. This strain was denoted MBX1509.  
       Example 15  
     PHBH Copolymer Producing Transgenic  E. coli  Strains  
       [0111]    [0111] E. coli  MBX240 is an XL1-blue (Stratagene, San Diego, Calif.) derivative with a chromosomally integrated copy of the PHB polymerase encoding phbC gene from  Ralsionia eutropha . This strain does not form PHAs from carbon sources such as glucose or fatty acids, because of the absence of enzymes converting acetyl-CoA (generated from carbohydrates such as glucose) or fatty acid oxidation intermediates, into (R)-3-hydroxyacyl-CoA monomers for polymerization. pMSXJ12 was constructed by inserting the phaJ gene from  A. caviae  digested with EcoRI and PstI into the corresponding sites of pUC18Sfi. The phaJ gene was obtained by polymerase chain reaction using the primers  
                                       Ac3-5′:               5′ AGAATTCAGGAGGACGCCGCATGAGCGCACAATCCCTGG                       and Ac3-3′:           5′ TTCCTGCAGCTCAAGGCAGCTTGACCACG            
         [0112]    using a PCR program including 30 cycles of 45 s at 95 C, 45 s at 55 C and 2.5 minutes at 72 C. Transformants of  E. coli  MBX240 with plasmid pMTXJ12 containing the (R)-specific enoyl-CoA hydratase encoded by the phaj gene from  Aeromonas caviae  were grown on Luria-Bertani medium with 10 mM octanoate and 1 mM oleate. After 48 hours of growth, cells were harvested from a 50 ml culture by centrifugation and the cell pellet lyophilized. Lyophilized cells were extracted with chloroform (8 ml) for 16 hours and PHA was specifically precipitated from the chloroform solution by adding the chloroform layer to a 10-fold excess ethanol. Precipitation was allowed to occur at 4 C and the solid polymer was air dried and analyzed for composition by acidic butanolysis. Butylated PHA monomers were separated by gas chromatography and identified the PHA as a poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) copolymer with 2.6% 3-hydroxyhexanoate monomers.  
       Example 16  
     Construction of Transgenic  E. coli  Strains for Screening of New and/or Improved Genes for PHA Production  
       [0113]    The phbC gene was introduced into an  E. coli  cloning strain by bacteriophage P1 transduction. In a procedure similar to that followed for phbC 5  integration, the phbC gene from  R. eutropha  was integrated into the chromosome of MBX23, resulting in MBX143. After chloramphenicol amplification, MBX150, which is resistant to 500 μg/ml chloramphenicol, was isolated. A bacteriophage P1 lysate grown on MBX150 was used to transduce the phbC-cat allele into XL1-Blue [pT7-RecA]. Plasmid pT7RecA expresses a functional RecA protein which is required for successful P1 transduction. The resulting strain MBX240 is an XL1-Blue derivative with a functional PHB polymerase expressed from the chromosome. MBX613 and MBX683 were developed using the same procedures. These strains were derived from MBX245 and XL1-Blue, respectively, and contain integrated AB 5 cat (MBX613) or p 13 AB 5 kan (MBX683) operons.  
       Example 17  
     Identification of Genes Encoding New, Improved or Ancillary PHA Biosynthetic Enzymes  
       [0114]    MBX240, 613, and 683 are three strains that can be used in screening procedures for new or improved PHA genes. Using these strains, the following genes have been identified: phbCABFA2 from  P. acidophila  and phbCAB from  A. latus . In addition, the phaJ gene from  A. caviae  was functionally expressed in MBX240 to produce PHA from fatty acids. Besides PHA biosynthetic genes specific for C 3  to C 6  monomers, PHA biosynthetic enzymes for PHAs consisting of medium side-chain 3-hydroxy acids can also be expressed in  E. coli . Such strains are useful in identifying additional PHA biosynthetic enzymes.  
       Example 18  
     Integration of pha Genes in  R. eutropha    
       [0115]    The plasmids described in the previous examples were used to integrate pha genes in  R. eutropha . Using a PHA-negative mutant of  R. eutropha  such as #2 (Peoples &amp; Sinskey,  J. Biol. Chem.  264:15298-303 (1989)) or PHB-4 (Schubert, et al.,  J. Bacteriol.  170:5837-47 (1988)), PHA formation was restored by integration of phaC from  A. caviae  in combination with phbAB from  Z. ramigera  or phaJ from  A. caviae . The resulting strains produced PHAs to variable levels, with a molecular weight in the range of 400,000 to 10,000,000 Da and with a composition that includes monomers such as 3-hydroxyhexanoate and 3-hydroxyoctanoate.  
       Example 19  
     Integration of pha Genes in  P. putida    
       [0116]    The plasmids described in the previous examples were used to integrate pha genes into  Pseudomonas putida . The PHA-negative phenotype of  P. putida  GPp104 (Huisman et al., J. Biol. Chem. 266:2191-98 (1991)) was restored by integration of a phaC3kan cassette where phaC3 encodes the PHA polymerase from  P. oleovorans . Integration of phaC3kan using pMUXC3kan was also applied to generate mutants of  P. putida  with mutations in genes encoding enzymes that affect PHA metabolism other than phaC. The PHA polymerase gene from  A. caviae  was also introduced in to the chromosome to result in a strain that produces PHAs including 3-hydroxy fatty acids in the C 3  to C 9  range.  
       Example 20  
     Chromosomal Integration of phaC Genes to Control Molecular Weight of the Resulting PHA  
       [0117]    It is well known that the concentration of PHA polymerase determines the molecular weight of the produced PHA when substrate is available in excess. Variation of the molecular weight is desirable as polymer properties are dependent on molecular weight. Chromosomal integration of phb genes results in variable levels of expression of the pha gene as determined by the chromosomal integration site. It is therefore possible to obtain different transgenic bacteria that have variable levels of phaC expression and hence produce PHAs of variable molecular weight. With this system, it is possible to produce PHAs with molecular weights of greater than 400,000 Da and frequently even in excess of 1,000,000 Da. This procedure is applicable to any gram-negative bacterium in which the pUT or pLOF derived plasmids can be introduced, such as  E. coli, R. eutropha, P. putida, Klebsiella pneumoniae, Alcaligenes latus, Azotobacter vinelandii, Burkholderia cepacia, Paracoccus denitrificans  and in general in species of the Escherichia, Pseudomonas, Ralstonia, Burkholderia, Alcaligenes, Klebsiella, Azotobacter genera.  
       Example 21  
     Integration of the PHB Genes as a Single Operon  
       [0118]    A plasmid, pMSXABC 5 kan, was constructed such that the thiolase (phbA), reductase (phbB), and PHB synthase (phbC) genes from  Zoogloea ramigera  and the kanamycin resistance gene (kan) were linked as an operon in the vector pUC18Sfi. This expression cassette was then excised as an AvrII fragment and inserted into the AvrII site of pUT to obtain pMUXABC 5 kan.  
         [0119]    S17-1 λpir strains with pMUXABC 5 kan were mated with MBX247. Transgenic strains in which phbABC 5 kan had integrated into the chromosome were selected on LB/N1/Km plates. Among the integrants, PHB producers were identified on LB/glucose plates. One strain thus constructed, MBX1164, was selected for further study.  
         [0120]    Thiolase (Nishimura et al., 1978, Arch. Microbiol. 116:21-24) and reductase (Saito et al., 1977, Arch. Microbiol. 114:211-217) assays were conducted on MBX1164 crude extracts. The cultures were grown in 50 mL of 0.5×E2 medium supplemented with 20 g/L glucose. One unit (U) was defined as the amount of enzyme that converted 1  82  mol of substrate to product per min. 3-Ketothiolase activity was determined to be 2.23±0.38 and 2.48±0.50 U/mg in two independent trials, and 3-hydroxybutyryl-CoA reductase activity was determined to be 4.10±1.51 and 3.87±0.15 U/mg in two independent trials.  
         [0121]    Strain MBX1164 was evaluated for its PHB-producing ability in square shake bottles. The cells were grown in 2 mL of LB, and 0.1 mL of this was used as an inoculum for the 50-mL shake bottle culture. The shake bottle contained E2 medium supplemented with 0.25% corn steep liquor (Sigma, St. Louis, Mo.) and 20 g/L glucose. After incubation at 30° C. for 48 hours with shaking at 200 rpm, the biomass concentration had reached 2.6 g/L, and the PHB concentration had reached 11.7 g/L; thus the cells contained 82% PHB by weight.  
       Example 22  
     Integration of the  Pseudomonas oleovorans  PHA Synthase into the  E. coli  Chromosome  
       [0122]    A PHA synthase (phaC) cassette from the  P. oleovorans  chromosome and a promoterless chloramphenicol resistance gene were inserted into pUC118 such that an operon of the two genes was formed; i.e., they were oriented in the same direction and could be transcribed on the same mRNA. The sequence of the  P. oleovorans  phaC gene is shown below. The phaC-cat operon was excised from this plasmid by digestion with KpnI and HindIII and ligated to pUC18SfiI that had been digested with the same two enzymes to form pMSXC 3 cat. This allowed the phaC-cat operon to be flanked by AvrII sites. The phaC-cat operon was removed from pMSXC 3 cat by digestion with AvrII and FspI. Because the two AvrII fragments of pMSXC 3 cat were nearly the same size, FspI was used to facilitate isolation of the phaC-cat operon by cutting the rest of the vector into two pieces. The AvrII fragment was ligated to pUTkan which had been digested with AvrII and treated with alkaline phosphatase to prevent self-ligation. The plasmid thus produced was denoted pMUXC 3 cat. The operon on this plasmid actually consisted of phaC-cat-kan. Strain CC118 λpir (a λpir lysogenic strain) was transformed with pMUXC 3 cat to produce strain MBX130. Equal amounts of strains MBX130 and MBX245 were mixed on an LB agar plate and incubated for 8 hours at 37° C. The mixed cells were then used as an inoculum for an overnight 37° C. culture of LB-chloramphenicol (25 μg/mL)-nalidixic acid (30 μg/mL). Single colonies were isolated from this culture by plating on LB-chloramphenicol (25 μg/mL)-nalidixic acid (30 μg/mL)-kanamycin (25 μg/mL). The colonies thus isolated have a transducible phaC-cat-kan cassette on the chromosome, as shown by the ability to use P1 transduction to introduce the cassette into the chromosome of other strains and select for resistance to both chloramphenicol and kanamycin.  
                                           Pseudomonas oleovorans  PHA synthase (phaC).                                ATGAGTAACAAGAACAACGATGAGCTGCAGCGGCAGGCCTCGGAAAACACCCTGGGGCTGAACCCGGTCATC                   GGTATCCGCCGCAAAGACCTGTTGAGCTCGGCACGCACCGTGCTGCGCCAGGCCGTGCGCCAACCGCTGCAC               AGCGCCAAGCATGTGGCCCACTTTGGCCTGGAGCTGAAGAACGTGCTGCTGGGCAAGTCCAGCCTTGCCCCG               GAAAGCGACGACCGTCGCTTCAATGACCCGGCATGGAGCAACAACCCACTTTACCGCCGCTACCTGCAAACC               TATCTGGCCTGGCGCAAGGAGCTGCAGGACTGGATCGGCAACAGCGACCTGTCGCCCCAGGACATCAGCCGC               GGCCAGTTCGTCATCAACCTGATGACCGAAGCCATGGCTCCGACCAACACCCTGTCCAACCCGGCAGCAGTC               AAACGCTTCTTCGAAACCGGCGGCAAGAGCCTGCTCGATGGCCTGTCCAACCTGGCCAAGGACCTGGTCAAC               AACGGTGGCATGCCCAGCCAGGTGAACATGGACGCCTTCGAGGTGGGCAAGAACCTGGGCACCAGTGAAGGC               GCCGTGGTGTACCGCAACGATGTGCTGGAGCTGATCCAGTACAACCCCATCACCGAGCAGGTGCATGCCCGC               CCGCTGCTGGTGGTGCCGCCGCAGATCAACAAGTTCTACGTATTCGACCTGAGCCCGGAAAAGAGCCTGGCA               CGCTACTGCCTGCGCTCGCAGCAGCAGACCTTCATCATCAGCTGGCGCAACCCGACCAAAGCCCAGCGCGAA               TGGGGCCTGTCCACCTACATCGACGCGCTCAAGGAGGCGGTCGACGCGGTGCTGGCGATTACCGGCAGCAAG               GACCTGAACATGCTCGGTGCCTGCTCCGGCGGCATCACCTGCACGGCATTGGTCGGCCACTATGCCGCCCTC               GGCGAAAACAAGGTCAATGCCCTGACCCTGCTGGTCAGCGTGCTGGACACCACCATGGACAACCAGGTCGCC               CTGTTCGTCGACGAGCAGACTTTGGAGGCCGCCAAGCGCCACTCCTACCAGGCCGGTGTGCTCGAAGGCAGC               GAGATGGCCAAGGTGTTCGCCTGGATGCGCCCCAACGACCTGATCTGGAACTACTGGGTCAACAACTACCTG               CTCGGCAACGAGCCGCCGGTGTTCGACATCCTGTTCTGGAACAACGACACCACGCGCCTGCCGGCCGCCTTC               CACGGCGACCTGATCGAAATGTTCAAGAGCAACCCGCTGACCCGCCCGGACGCCCTGGAGGTTTGCGGCACT               CCGATCGACCTGAAACAGGTCAAATGCGACATCTACAGCCTTGCCGGCACCAACGACCACATCACCCCGTGG               CAGTCATGCTACCGCTCGGCGCACCTGTTCGGCGGCAAGATCGAGTTCGTGCTGTCCAACAGCGGCCACATC               CAGAGCATCCTCAACCCGCCAGGCAACCCCAAGGCGCGCTTCATGACCGGTGCCGATCGCCCGGGTGACCCG               GTGGCCTGGCAGGAAAACGCCACCAAGCATGCCGACTCCTGGTGGCTGCACTGGCAAAGCTGGCTGGGCGAG               CGTGCCGGCGAGCTGAAAAAGGCGCCGACCCGCCTGGGCAACCGTGCCTATGCCGCTGGCGAGGCATCCCCG               GGCACCTACGTTCACGAGCGTTGA                  
 
         [0123]    Modifications and variations of the present invention will be obvious to those of skill in the art from the foregoing detailed description. Such modifications and variations are intended to come within the scope of the following claims.  
     
       
       
         1 
         
           
             39  
           
           
             1  
             50  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence 
      oligonucleotide  
             
           
            1 

aagcttccca gcccgctaat gagcgggctt ttttttgaac aaaagcatgc                50 

 
           
             2  
             71  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence 
      oligonucleotide  
             
           
            2 

gtctacgtac cccaggcttt acatttatgc ttccggctcg tatgttgtgt ggaattgtga     60 

gcggttcgga c                                                          71 

 
           
             3  
             48  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence 
      oligonucleotide  
             
           
            3 

agcttcccag cccgctaatg agcgggcttt tttttgaaca aaagctgc                  48 

 
           
             4  
             40  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence 
      oligonucleotide  
             
           
            4 

cttttgttca aaaaaaagcc cgctcattag cgggctggga                           40 

 
           
             5  
             45  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence 
      oligonucleotide  
             
           
            5 

ggctcgtata atgtgtggag ggagaaccgc cgggctcgcg ccgtt                     45 

 
           
             6  
             53  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence 
      oligonucleotide  
             
           
            6 

ctagaacggc gcgagcccgg cggttctccc tccacacatt atacgagcct gca            53 

 
           
             7  
             43  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence 
      oligonucleotide  
             
           
            7 

ttcagaaaat tattttaaat ttcctcttga catttatgct gca                       43 

 
           
             8  
             43  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence 
      oligonucleotide  
             
           
            8 

gcataaatgt caagaggaaa tttaaaataa ttttctgaat gca                       43 

 
           
             9  
             58  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence 
      oligonucleotide  
             
           
            9 

ctagtgccgg acccggttcc aaggccggcc gcaaggctgc cagaactgag gaagcaca       58 

 
           
             10  
             56  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence 
      oligonucleotide  
             
           
            10 

tatgtgcttc ctcagttctg gcagccttgc ggccggcctt ggaaccgggt ccggca         56 

 
           
             11  
             26  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence 
      oligonucleotide  
             
           
            11 

tcccctgtca taaagttgtc actgca                                          26 

 
           
             12  
             26  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence 
      oligonucleotide  
             
           
            12 

gtgacaactt tatgacaggg gatgca                                          26 

 
           
             13  
             19  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence 
      oligonucleotide  
             
           
            13 

tgaccaacat acgagcggc                                                  19 

 
           
             14  
             20  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence 
      oligonucleotide  
             
           
            14 

ctaccagaac tttgctttcc                                                 20 

 
           
             15  
             36  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence 
      oligonucleotide  
             
           
            15 

tgcatgcgat atcaattgtc cagccagaaa gtgagg                               36 

 
           
             16  
             20  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence 
      oligonucleotide  
             
           
            16 

atttattcaa caaagccgcc                                                 20 

 
           
             17  
             38  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence 
      oligonucleotide  
             
           
            17 

cccagcccgc taatgagcgg gctttttttt gaacaaaa                             38 

 
           
             18  
             44  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence 
      oligonucleotide  
             
           
            18 

tacgtatttt gttcaaaaaa aagcccgctc attagcgggc tggg                      44 

 
           
             19  
             63  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence 
      oligonucleotide  
             
           
            19 

tacgtacccc aggctttaca tttatgcttc cggctcgtat gttgtgtgga attgtgagcg     60 

gtt                                                                   63 

 
           
             20  
             61  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence 
      oligonucleotide  
             
           
            20 

ttcgaaccgc tcacaattcc acacaacata cgagccggaa gcataaatgt aaagcctggg     60 

g                                                                     61 

 
           
             21  
             14  
             DNA  
             Pseudomonas oleovorans  
           
            21 

aggaggtttt tatg                                                       14 

 
           
             22  
             42  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence primer  
             
           
            22 

ggaattcagg aggttttatg gcgaccggca aaggcgcggc ag                        42 

 
           
             23  
             38  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence primer  
             
           
            23 

gctctagaag ctttcatgcc ttggctttga cgtatcgc                             38 

 
           
             24  
             42  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence primer  
             
           
            24 

ggaattcagg aggttttatg agtaacaaga acaacgatga gc                        42 

 
           
             25  
             38  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence primer  
             
           
            25 

gctctagaag ctttcaacgc tcgtgaacgt aggtgccc                             38 

 
           
             26  
             42  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence primer  
             
           
            26 

ggaattcagg aggttttatg agccaaccat cttatggccc gc                        42 

 
           
             27  
             38  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence primer  
             
           
            27 

gctctagaag ctttcatgcg gcgtcctcct ctgttggg                             38 

 
           
             28  
             42  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence primer  
             
           
            28 

ggaattcagg aggttttatg aggccagaaa tcgctgtact tg                        42 

 
           
             29  
             38  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence primer  
             
           
            29 

gctctagaag ctttcagatg gcaaatgcat gctgcccc                             38 

 
           
             30  
             43  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence primer  
             
           
            30 

aggagctcag gaggttttat gagcgcacaa tccctggaag tag                       43 

 
           
             31  
             38  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence primer  
             
           
            31 

gctctagaag cttttaaggc agcttgacca cggcttcc                             38 

 
           
             32  
             43  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence primer  
             
           
            32 

ggaattcagg aggttttatg acgcgtgaag tggtagtggt aag                       43 

 
           
             33  
             37  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence primer  
             
           
            33 

gctctagaag ctttcagata cgctcgaaga tggcggc                              37 

 
           
             34  
             42  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence primer  
             
           
            34 

ggaattcagg aggttttatg atcctcaccc cggaacaagt tg                        42 

 
           
             35  
             38  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence primer  
             
           
            35 

gctctagaag ctttcagggc actaccttca tcgttggc                             38 

 
           
             36  
             38  
             DNA  
             Artificial Sequence  
             
               Description of Artificial Sequence primer  
             
           
            36 

gctctagaag ctttcaggca gccgtcgtct tctttgcc                             38 

 
           
             37  
             39  
             DNA  
             Aeromonas caviae  
           
            37 

agaattcagg aggacgccgc atgagcgcac aatccctgg                            39 

 
           
             38  
             29  
             DNA  
             Aeromonas caviae  
           
            38 

ttcctgcagc tcaaggcagc ttgaccacg                                       29 

 
           
             39  
             1680  
             DNA  
             Pseudomonas oleovorans  
           
            39 

atgagtaaca agaacaacga tgagctgcag cggcaggcct cggaaaacac cctggggctg     60 

aacccggtca tcggtatccg ccgcaaagac ctgttgagct cggcacgcac cgtgctgcgc    120 

caggccgtgc gccaaccgct gcacagcgcc aagcatgtgg cccactttgg cctggagctg    180 

aagaacgtgc tgctgggcaa gtccagcctt gccccggaaa gcgacgaccg tcgcttcaat    240 

gacccggcat ggagcaacaa cccactttac cgccgctacc tgcaaaccta tctggcctgg    300 

cgcaaggagc tgcaggactg gatcggcaac agcgacctgt cgccccagga catcagccgc    360 

ggccagttcg tcatcaacct gatgaccgaa gccatggctc cgaccaacac cctgtccaac    420 

ccggcagcag tcaaacgctt cttcgaaacc ggcggcaaga gcctgctcga tggcctgtcc    480 

aacctggcca aggacctggt caacaacggt ggcatgccca gccaggtgaa catggacgcc    540 

ttcgaggtgg gcaagaacct gggcaccagt gaaggcgccg tggtgtaccg caacgatgtg    600 

ctggagctga tccagtacaa ccccatcacc gagcaggtgc atgcccgccc gctgctggtg    660 

gtgccgccgc agatcaacaa gttctacgta ttcgacctga gcccggaaaa gagcctggca    720 

cgctactgcc tgcgctcgca gcagcagacc ttcatcatca gctggcgcaa cccgaccaaa    780 

gcccagcgcg aatggggcct gtccacctac atcgacgcgc tcaaggaggc ggtcgacgcg    840 

gtgctggcga ttaccggcag caaggacctg aacatgctcg gtgcctgctc cggcggcatc    900 

acctgcacgg cattggtcgg ccactatgcc gccctcggcg aaaacaaggt caatgccctg    960 

accctgctgg tcagcgtgct ggacaccacc atggacaacc aggtcgccct gttcgtcgac   1020 

gagcagactt tggaggccgc caagcgccac tcctaccagg ccggtgtgct cgaaggcagc   1080 

gagatggcca aggtgttcgc ctggatgcgc cccaacgacc tgatctggaa ctactgggtc   1140 

aacaactacc tgctcggcaa cgagccgccg gtgttcgaca tcctgttctg gaacaacgac   1200 

accacgcgcc tgccggccgc cttccacggc gacctgatcg aaatgttcaa gagcaacccg   1260 

ctgacccgcc cggacgccct ggaggtttgc ggcactccga tcgacctgaa acaggtcaaa   1320 

tgcgacatct acagccttgc cggcaccaac gaccacatca ccccgtggca gtcatgctac   1380 

cgctcggcgc acctgttcgg cggcaagatc gagttcgtgc tgtccaacag cggccacatc   1440 

cagagcatcc tcaacccgcc aggcaacccc aaggcgcgct tcatgaccgg tgccgatcgc   1500 

ccgggtgacc cggtggcctg gcaggaaaac gccaccaagc atgccgactc ctggtggctg   1560 

cactggcaaa gctggctggg cgagcgtgcc ggcgagctga aaaaggcgcc gacccgcctg   1620 

ggcaaccgtg cctatgccgc tggcgaggca tccccgggca cctacgttca cgagcgttga   1680